Catalytic enhancements in cytochrome P450 2C19 by cytochrome
Cytochrome P450
Cytochrome b5
Omeprazole
P450 2C19
Progesterone
Journal
Toxicological research
ISSN: 1976-8257
Titre abrégé: Toxicol Res
Pays: Singapore
ID NLM: 101483324
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
received:
08
08
2023
revised:
31
10
2023
accepted:
23
11
2023
pmc-release:
01
04
2025
medline:
25
3
2024
pubmed:
25
3
2024
entrez:
25
3
2024
Statut:
epublish
Résumé
Human cytochrome P450 2C19 catalyzes P450 enzyme reactions of various substrates, including steroids and clinical drugs. Recombinant P450 2C19 enzyme with histidine tag was successfully expressed in The online version contains supplementary material available at 10.1007/s43188-023-00219-8.
Identifiants
pubmed: 38525137
doi: 10.1007/s43188-023-00219-8
pii: 219
pmc: PMC10959859
doi:
Types de publication
Journal Article
Langues
eng
Pagination
215-222Informations de copyright
© The Author(s) under exclusive licence to Korean Society of Toxicology 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Déclaration de conflit d'intérêts
Conflict of interestThe authors declare that they have no conflict of interest with the contents of this article.